Neoadjuvant nab-paclitaxel in the treatment of breast cancer

por Ueno, Naoto T., Mamounas, Eleftherios P.
Publicado 2016

Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Rev...

por Gunia, Sommer R., Patel, Mita S., Mamounas, Eleftherios P.
Publicado 2012

Clinical relevance of the 21-gene Recurrence Score(®) assay in treatment decisions for patients with node-positive breast cancer in the genomic era

por Mamounas, Eleftherios P., Russell, Christy A., Lau, Anna, Turner, Michelle P., Albain, Kathy S.
Publicado 2018

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination

por Swain, Sandra M., Tang, Gong, Lucas, Peter C., Robidoux, André, Goerlitz, David, Harris, Brent T., Bandos, Hanna, Geyer, Charles E., Rastogi, Priya, Mamounas, Eleftherios P., Wolmark, Norman
Publicado 2019

21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer

por Geyer, Charles E., Tang, Gong, Mamounas, Eleftherios P., Rastogi, Priya, Paik, Soonmyung, Shak, Steven, Baehner, Frederick L., Crager, Michael, Wickerham, D. Lawrence, Costantino, Joseph P., Wolmark, Norman
Publicado 2018

NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab

por Ganz, Patricia A., Cecchini, Reena S., Fehrenbacher, Louis, Geyer, Charles E., Rastogi, Priya, Crown, John P., Thirlwell, Michael P., Ellison, David M., Boileau, Jean-Francois, Flynn, Patrick J., Jeong, Jong-Hyeon, Mamounas, Eleftherios P., Wolmark, Norman
Publicado 2021

Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer

por Denkert, Carsten, Lambertini, Chiara, Fasching, Peter A., Pogue-Geile, Katherine L., Mano, Max S., Untch, Michael, Wolmark, Norman, Huang, Chiun-Sheng, Loibl, Sibylle, Mamounas, Eleftherios P., Geyer, Charles E., Lucas, Peter C., Boulet, Thomas, Song, Chunyan, Lewis, Gail D., Nowicka, Malgorzata, de Haas, Sanne, Basik, Mark
Publicado 2023

Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831

por Pogue-Geile, Katherine L, Song, Nan, Serie, Daniel J, Wang, Ying, Gavin, Patrick G, Kim, Rim S, Tanaka, Noriko, Fumagalli, Debora, Taniyama, Yusuke, Li, Zhuo, Rastogi, Priya, Swain, Sandra M, Mamounas, Eleftherios P, Geyer, Charles E, Wolmark, Norman, Lucas, Peter C, Paik, Soonmyung, Thompson, E Aubrey
Publicado 2020

MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice

por Paterson, Alexander H G, Lucas, Peter C, Anderson, Stewart J, Mamounas, Eleftherios P, Brufsky, Adam, Baez-Diaz, Luis, King, Karen M, Lad, Thomas, Robidoux, André, Finnigan, Melanie, Sampayo, Miguel, Tercero, Juan Carlos, Mairet, Joël Jean, Wolff, Antonio C, Fehrenbacher, Louis, Wolmark, Norman, Gomis, Roger R
Publicado 2021

Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE

por Loibl, Sibylle, Huang, Chiun-Sheng, Mano, Max S., Mamounas, Eleftherios P., Geyer, Charles E., Untch, Michael, Thery, Jean-Christophe, Schwaner, Ingo, Limentani, Steven, Loman, Niklas, Lübbe, Kristina, Chang, Jenny C., Hatschek, Thomas, Tesarowski, David, Song, Chunyan, Lysbet de Haas, Sanne, Boulet, Thomas, Lambertini, Chiara, Wolmark, Norman
Publicado 2022

Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial

por Advani, Pooja P., Ruddy, Kathryn J., Herrmann, Joerg, Ray, Jordan C., Craver, Emily C., Yothers, Greg, Cecchini, Reena S., Lipchik, Corey, Feng, Huichen, Rastogi, Priya, Mamounas, Eleftherios P., Swain, Sandra M., Geyer, Charles E., Wolmark, Norman, Paik, Soonmyung, Pogue-Geile, Katherine L., Colon-Otero, Gerardo, Perez, Edith A., Norton, Nadine
Publicado 2023

Patient‐reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy...

por Conte, PierFranco, Schneeweiss, Andreas, Loibl, Sibylle, Mamounas, Eleftherios P., von Minckwitz, Gunter, Mano, Max S., Untch, Michael, Huang, Chiun‐Sheng, Wolmark, Norman, Rastogi, Priya, D’Hondt, Veronique, Redondo, Andrés, Stamatovic, Ljiljana, Bonnefoi, Hervé, Castro‐Salguero, Hugo, Fischer, Hans H., Wahl, Tanya, Song, Chunyan, Boulet, Thomas, Trask, Peter, Geyer, Charles E.
Publicado 2020

Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ

por Manders, Jennifer B., Kuerer, Henry M., Smith, Benjamin D., McCluskey, Cornelia, Farrar, William B., Frazier, Thomas G., Li, Linna, Leonard, Charles E., Carter, Dennis L., Chawla, Sheema, Medeiros, Lori E., Guenther, J. Michael, Castellini, Lauren E., Buchholz, Daniel J., Mamounas, Eleftherios P., Wapnir, Irene L., Horst, Kathleen C., Chagpar, Anees, Evans, Suzanne B., Riker, Adam I., Vali, Faisal S., Solin, Lawrence J., Jablon, Lisa, Recht, Abram, Sharma, Ranjna, Lu, Ruixiao, Sing, Amy P., Hwang, E. Shelley, White, Julia
Publicado 2016

Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations

por Dowling, Ryan J O, Kalinsky, Kevin, Hayes, Daniel F, Bidard, Francois-Clement, Cescon, David W, Chandarlapaty, Sarat, Deasy, Joseph O, Dowsett, Mitch, Gray, Robert J, Henry, N Lynn, Meric-Bernstam, Funda, Perlmutter, Jane, Sledge, George W, Bratman, Scott V, Carey, Lisa A, Chang, Martin C, DeMichele, Angela, Ennis, Marguerite, Jerzak, Katarzyna J, Korde, Larissa A, Lohmann, Ana Elisa, Mamounas, Eleftherios P, Parulekar, Wendy R, Regan, Meredith M, Schramek, Daniel, Stambolic, Vuk, Thorat, Mangesh A, Whelan, Timothy J, Wolff, Antonio C, Woodgett, Jim R, Sparano, Joseph A, Goodwin, Pamela J
Publicado 2019

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions

por Dowling, Ryan J O, Sparano, Joseph A, Goodwin, Pamela J, Bidard, Francois-Clement, Cescon, David W, Chandarlapaty, Sarat, Deasy, Joseph O, Dowsett, Mitch, Gray, Robert J, Henry, N Lynn, Meric-Bernstam, Funda, Perlmutter, Jane, Sledge, George W, Thorat, Mangesh A, Bratman, Scott V, Carey, Lisa A, Chang, Martin C, DeMichele, Angela, Ennis, Marguerite, Jerzak, Katarzyna J, Korde, Larissa A, Lohmann, Ana Elisa, Mamounas, Eleftherios P, Parulekar, Wendy R, Regan, Meredith M, Schramek, Daniel, Stambolic, Vuk, Whelan, Timothy J, Wolff, Antonio C, Woodgett, Jim R, Kalinsky, Kevin, Hayes, Daniel F
Publicado 2019